Old North State Trust’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,015
Closed -$93K 327
2023
Q1
$93K Hold
1,015
0.06% 193
2022
Q4
$92K Hold
1,015
0.06% 191
2022
Q3
$77K Buy
+1,015
New +$84.1K 0.07% 181
2022
Q1
Sell
-879
Closed -$77K 270
2021
Q4
$77K Buy
879
+470
+115% +$39K 0.06% 186
2021
Q3
$33K Hold
409
0.03% 215
2021
Q2
$37K Hold
409
0.03% 226
2021
Q1
$35K Sell
409
-141
-26% -$12.7K 0.03% 227
2020
Q4
$52K Sell
550
-1,069
-66% -$93.4K 0.04% 195
2020
Q3
$141K Buy
+1,619
New +$140K 0.09% 120
2020
Q1
Sell
-754
Closed -$71K 258
2019
Q4
$71K Sell
754
-47
-6% -$4.22K 0.04% 181
2019
Q3
$70K Sell
801
-285
-26% -$25.6K 0.05% 186
2019
Q2
$99K Sell
1,086
-84
-7% -$7.11K 0.07% 158
2019
Q1
$100K Buy
1,170
+359
+44% +$28.8K 0.07% 158
2018
Q4
$62K Buy
811
+92
+13% +$7.16K 0.06% 178
2018
Q3
$55K Buy
+719
New +$53.2K 0.05% 197

Other funds holding NVS

Old North State Trust's NVS Position: Q2 2023 in Review

Old North State Trust sold out of Novartis (NVS) in Q2 2023, closing a stake of 1,015 shares — an estimated $93K sold.

Old North State Trust first reported a position in NVS in Q3 2018 and held it in 15 quarters. The position peaked at $141K in Q3 2020. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

  • Old North State Trust reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
  • Old North State Trust sold 1,015 Novartis shares in Q2 2023, an estimated $93K.
  • Old North State Trust first reported a position in Novartis in Q3 2018 and held it in 15 quarters.
  • Old North State Trust's Novartis position peaked at $141K in Q3 2020.
  • 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on Old North State Trust's 13F filing for Q2 2023, filed 22 Aug 2023.